Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID

Showing 12 posts of 57 posts found.

who_flag

WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir

July 6, 2020
Sales and Marketing COVID, COVID-19, WHO, coronavirus

The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 24, 2020
Research and Development COVID, COVID-19, coronavirus

Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …

News
contact_me

Experts warn UK government that unnecessary deaths will occur if lockdown is lifted before contact tracing system is implemented

June 18, 2020
Business Services COVID, COVID-19, coronavirus

The British government is risking many unnecessary deaths if it lifts the lockdown before an effective contact tracing system is …

News
wuhan_citiy

Fear of a coronavirus second wave as China reports highest number of cases in months

June 15, 2020
Sales and Marketing COVID, COVID-19, coronavirus, pandemic

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …

News
az_vaccinessssssssssss

AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses

June 15, 2020
Sales and Marketing COVID, COVID-19, Vaccine, coronavirus

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

News
eli_lilly

Eli Lilly’s coronavirus antibody treatments could be available by September

June 11, 2020
Business Services COVID, COVID-19, coronavirus

An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …

News
nhs_hospit

Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic

June 8, 2020
Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic

Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …

News
world

WHO stops hydroxychloroquine trial due to safety concerns

May 26, 2020
Manufacturing and Production COVID, COVID-19, coronavirus

The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, …

News
antibody

FDA grants Abbott Emergency Use Authorization for another COVID-19 antibody test

May 12, 2020
Manufacturing and Production COVID, COVID-19, coronavirus, pandemic, tests

The FDA has given Emergency Use Authorisation for another COVID-19 diagnostics test for antibodies from Abbott Laboratories. With this approval, …

News
social_distancing

Intermittent social distancing could last until 2022, according to a new study

April 16, 2020
Business Services COVID, COVID-19, coronavirus, social distancing

Social distancing that has been put in place to stem the spread of COVID-19 coronavirus could be implemented up until …

News

US to suspend funding of the World Health Organization amidst review

April 15, 2020
Research and Development COVID, COVID-19, coronavirus

US President Donald Trump has announced the US will stop funding the World Health Organization due to allegations that they …

News
00_transportation_isolation_system_1

Results released from first clinical trial using Danoprevir to treat COVID-19

March 25, 2020
Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus

The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …

News

Latest content

GSK’s Jemperli approved in EU as treatment for endometrial cancer

December 11, 2023

Daiichi Sankyo shares results for Ezharmia as lymphoma treatment

December 11, 2023

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023